TPI Composites files for Chapter 11 bankruptcy, plans delisting from Nasdaq
James P. Zallie, the President and CEO of Ingredion Inc (NYSE:INGR), recently sold a significant portion of his holdings in the company. According to a recent SEC filing, Zallie sold 39,329 shares of common stock on February 14, 2025. The shares were sold at a weighted average price of $126.905, resulting in a total transaction value of approximately $4.99 million. This sale was conducted under a Rule 10b5-1 trading plan that Zallie adopted in November 2024. The transaction comes as Ingredion maintains strong financial health, with InvestingPro data showing a solid current ratio of 2.62 and a 28-year track record of consistent dividend payments.
Following the transaction, Zallie retains ownership of 52,757.5701 shares directly. The stock sales were executed in multiple transactions, with prices ranging from $126.170 to $128.645 per share. Zallie’s trading activity comes as part of a pre-established plan, providing a structured approach to managing his holdings in Ingredion. Currently trading at a P/E ratio of 12.66 and showing strong free cash flow yields, InvestingPro analysis indicates the stock may be undervalued. For deeper insights into Ingredion’s valuation and financial metrics, including 10+ additional ProTips and comprehensive analysis, investors can access the full Pro Research Report on InvestingPro.
In other recent news, Ingredion has seen adjustments to its stock price target by various analysts following its fourth-quarter earnings report. BMO Capital Markets decreased its price target to $133 while maintaining a Market Perform rating, citing the company’s fourth-quarter earnings per share (EPS) of $2.63, which exceeded the $2.56 consensus. Ingredion also issued EPS guidance for 2025, ranging from $10.75 to $11.55, which includes the consensus estimates.
In a similar move, Stephens revised Ingredion’s price target to $150, maintaining an Equal Weight rating. The company’s fourth-quarter adjusted earnings per share (EPS) of $2.65 surpassed Stephens’ estimate of $2.54 and the consensus estimate of $2.57. Ingredion also anticipates approximately 5% growth in EPS for fiscal year 2025.
Oppenheimer also adjusted its outlook, reducing the price target from $178.00 to $167.00, but keeping an Outperform rating. This followed Ingredion’s fourth-quarter earnings report and its conservative forecast for 2025.
Additionally, Ingredion announced plans to cease operations at its Vanscoy, Saskatchewan manufacturing facility, anticipating a pre-tax non-recurring charge of approximately $66 million. These developments are part of the company’s recent events, shaping its outlook for the upcoming fiscal year.
This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.